Iron and thiols as two major players in carcinogenesis: Friends or foes?

Frontiers in Pharmacology

Volumn 5 AUG, Issue , 2014, Pages

  Toyokuni, Shinya ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Cancer stem cell; Carcinogenesis; Chelate; Ferroptosis; Glutathione; Iron; Nrf2; Oxidative stress; Peroxiredoxins; Redox; Thiol compounds

Indexed keywords

CYSTINE; DNA; GLUTAMATE TRANSPORTER; HYDROGEN PEROXIDE; IRON; KELCH LIKE ECH ASSOCIATED PROTEIN 1; PROTEIN KINASE INHIBITOR; THIOL; TRANSCRIPTION FACTOR NRF2;

ARTICLE; CANCER PREVENTION; CANCER RISK; CANCER STEM CELL; CARCINOGENESIS; CELL DEATH; CELL PROLIFERATION; DOUBLE STRANDED DNA BREAK; GENE AMPLIFICATION; GENE IDENTIFICATION; GENE MUTATION; HUMAN; IRON OVERLOAD; KEAP1 GENE; NEOPLASM; NONHUMAN; NRF2 GENE; ONCOGENE; OXIDATIVE STRESS; PROTEIN EXPRESSION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

EID: 84906283034     PISSN: None     EISSN: 16639812     Source Type: Journal    
DOI: 10.3389/fphar.2014.00200     Document Type: Article

References (132)

1. Agudo, A., Bonet, C., Sala, N., Munoz, X., Aranda, N., Fonseca-Nunes, A., Clavel-Chapelon, F., Boutron-Ruault, M.C., Vineis, P., Panico, S., Palli, D., Tumino, R., Grioni, S., Quiros, J.R., Molina, E., Navarro, C., Barricarte, A., Chamosa, S., Allen, N.E., Khaw, K.T., Bueno-De-Mesquita, H.B., Siersema, P.D., Numans, M.E., Trichopoulou, A., Lagiou, P., Trichopoulos, D., Kaaks, R., Canzian, F., Boeing, H., Meidtner, K., Johansson, M., Sund, M., Manjer, J., Overvad, K., Tjonneland, A., Lund, E., Weiderpass, E., Jenab, M., Fedirko, V., Offerhaus, G.J., Riboli, E., Gonzalez, C.A., and Jakszyn, P. (2013). Hemochromatosis (HFE) gene mutations and risk of gastric cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Carcinogenesis 34, 1244-1250. doi: 10.1093/carcin/bgt045.
2. Aierken, D., Okazaki, Y., Chew, S.H., Sakai, A., Wang, Y., Nagai, H., Misawa, N., Kohyama, N., and Toyokuni, S. (2014). Rat model demostrates a high risk of tremolite but a low risk of anthophyllite for mesothelial carcinogenesis. Nagoya J Med Sci 76, 149-160.
3. Akatsuka, S., Yamashita, Y., Ohara, H., Liu, Y.T., Izumiya, M., Abe, K., Ochiai, M., Jiang, L., Nagai, H., Okazaki, Y., Murakami, H., Sekido, Y., Arai, E., Kanai, Y., Hino, O., Takahashi, T., Nakagama, H., and Toyokuni, S. (2012). Fenton reaction induced cancer in wild type rats recapitulates genomic alterations observed in human cancer. PLoS ONE 7, e43403.
4. Albanes, D., Heinonen, O., Taylor, P., Virtamo, J., Edwards, B., Rautalahti, M., Hartman, A., Palmgren, J., Freedman, L., Haapakoski, J., Barrett, M., Pietinen, P., Malila, N., Tala, E., Liippo, K., Salomaa, E., Tangrea, J., Teppo, L., Askin, F., Taskinen, E., Erozan, Y., Greenwald, P., and Huttunen, J. (1996). Alpha-Tocopherol and beta-carotene supplements and lung cancer incidence in the alpha-tocopherol, beta-carotene cancer prevention study: effects of base-line characteristics and study compliance. J Natl Cancer Inst 88, 1560-1570.
5. Anderson, R.L., Alden, C.L., and Merski, J.A. (1982). The effects of nitrilotriacetate on cation disposition and urinary tract toxicity. Food Chem Toxicol 20, 105-122.
6. Antunes, F., and Cadenas, E. (2000). Estimation of H2O2 gradients across biomembranes. FEBS Lett 475, 121-126.
7. Awai, M., Narasaki, M., Yamanoi, Y., and Seno, S. (1979). Induction of diabetes in animals by parenteral administration of ferric nitrilotriacetate: a model of experimental hemochromatosis. Am.J.Pathol. 95, 663-674.
8. Beckman, J.A., Creager, M.A., and Libby, P. (2002). Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. JAMA 287, 2570-2581.
9. Bedard, K., and Krause, K.H. (2007). The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol Rev 87, 245-313. doi: 10.1152/physrev.00044.2005.
10. Beguin, Y., Aapro, M., Ludwig, H., Mizzen, L., and Osterborg, A. (2014). Epidemiological and nonclinical studies investigating effects of iron in carcinogenesis--a critical review. Crit Rev Oncol Hematol 89, 1-15. doi: 10.1016/j.critrevonc.2013.10.008.
11. Bienert, G.P., Moller, A.L., Kristiansen, K.A., Schulz, A., Moller, I.M., Schjoerring, J.K., and Jahn, T.P. (2007). Specific aquaporins facilitate the diffusion of hydrogen peroxide across membranes. J Biol Chem 282, 1183-1192. doi: 10.1074/jbc.M603761200.
12. Bienert, G.P., Schjoerring, J.K., and Jahn, T.P. (2006). Membrane transport of hydrogen peroxide. Biochim Biophys Acta 1758, 994-1003. doi: 10.1016/j.bbamem.2006.02.015.
13. Bjelakovic, G., Nikolova, D., Gluud, L.L., Simonetti, R.G., and Gluud, C. (2007). Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis. JAMA 297, 842-857. doi: 10.1001/jama.297.8.842.
14. Bjelakovic, G., Nikolova, D., Simonetti, R.G., and Gluud, C. (2004). Antioxidant supplements for prevention of gastrointestinal cancers: a systematic review and meta-analysis. Lancet 364, 1219-1228. doi: 10.1016/S0140-6736(04)17138-9.
15. Bonkovsky, H.L., Banner, B.F., and Rothman, A.L. (1997). Iron and chronic viral hepatitis. Hepatology 25, 759-768. doi: 10.1002/hep.510250345.
16. Brigelius-Flohe, R., and Maiorino, M. (2013). Glutathione peroxidases. Biochim Biophys Acta 1830, 3289-3303. doi: 10.1016/j.bbagen.2012.11.020.
17. Cadenas, E., and Davies, K.J. (2000). Mitochondrial free radical generation, oxidative stress, and aging. Free Radic Biol Med 29, 222-230.
18. Camacho, C.V., Todorova, P.K., Hardebeck, M.C., Tomimatsu, N., Gil Del Alcazar, C.R., Ilcheva, M., Mukherjee, B., Mcellin, B., Vemireddy, V., Hatanpaa, K., Story, M.D., Habib, A.A., Murty, V.V., Bachoo, R., and Burma, S. (2014). DNA double-strand breaks cooperate with loss of Ink4 and Arf tumor suppressors to generate glioblastomas with frequent Met amplification. Oncogene. doi: 10.1038/onc.2014.29.
19. Campbell, J.A. (1940). Effects of precipitated silica and of iron oxide on the incidence of primary lung tumours in mice. Br. Med. J. August 31, 275-280.
20. Cho, M., Eze, O.P., and Xu, R. (2013). A brief review of the controversial role of iron in colorectal carcinogenesis. J Clin Exp Pathol 3, 137.
21. Dawson, M.A., and Kouzarides, T. (2012). Cancer epigenetics: from mechanism to therapy. Cell 150, 12-27. doi: 10.1016/j.cell.2012.06.013.
22. Dennehy, M.K., Richards, K.A., Wernke, G.R., Shyr, Y., and Liebler, D.C. (2006). Cytosolic and nuclear protein targets of thiol-reactive electrophiles. Chem Res Toxicol 19, 20-29. doi: 10.1021/tx050312l.
23. Devireddy, L.R., Hart, D.O., Goetz, D.H., and Green, M.R. (2010). A mammalian siderophore synthesized by an enzyme with a bacterial homolog involved in enterobactin production. Cell 141, 1006-1017.
24. Dixon, S.J., Lemberg, K.M., Lamprecht, M.R., Skouta, R., Zaitsev, E.M., Gleason, C.E., Patel, D.N., Bauer, A.J., Cantley, A.M., Yang, W.S., Morrison, B., 3rd, and Stockwell, B.R. (2012). Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell 149, 1060-1072. doi: 10.1016/j.cell.2012.03.042.
25. Dizdaroglu, M. (1991). Chemical determination of free radical-induced damage to DNA. Free Radic Biol Med 10, 225-242.
26. Dutta, K.K., Nishinaka, Y., Masutani, H., Akatsuka, S., Aung, T.T., Shirase, T., Lee, W.H., Yamada, Y., Hiai, H., Yodoi, J., and Toyokuni, S. (2005). Two distinct mechanisms for loss of thioredoxin-binding protein-2 in oxidative stress-induced renal carcinogenesis. Lab Invest 85, 798-807. doi: 3700280 [pii] 10.1038/labinvest.3700280 [doi].
27. Ebina, Y., Okada, S., Hamazaki, S., Ogino, F., Li, J.L., and Midorikawa, O. (1986). Nephrotoxicity and renal cell carcinoma after use of iron- and aluminumnitrilotriacetate complexes in rats. J Natl Cancer Inst 76, 107-113
28. Enami, S., Sakamoto, Y., and Colussi, A.J. (2014). Fenton chemistry at aqueous interfaces. Proc Natl Acad Sci U S A 111, 623-628. doi: 10.1073/pnas.1314885111.
29. Esteller, M., and Herman, J.G. (2002). Cancer as an epigenetic disease: DNA methylation and chromatin alterations in human tumours. J Pathol 196, 1-7. doi: 10.1002/path.1024.
30. Fabbro, D., Cowan-Jacob, S.W., Mobitz, H., and Martiny-Baron, G. (2012). Targeting cancer with small-molecular-weight kinase inhibitors. Methods Mol Biol 795, 1-34. doi: 10.1007/978-1-61779-337-0_1.
31. Feinberg, A.P., Ohlsson, R., and Henikoff, S. (2006). The epigenetic progenitor origin of human cancer. Nat Rev Genet 7, 21-33. doi: 10.1038/nrg1748.
32. Fonseca-Nunes, A., Jakszyn, P., and Agudo, A. (2014). Iron and cancer risk--a systematic review and meta-analysis of the epidemiological evidence. Cancer Epidemiol Biomarkers Prev 23, 12-31. doi: 10.1158/1055-9965.EPI-13-0733.
33. Fracanzani, A., Conte, D., Fraquelli, M., Taioli, E., Mattioli, M., Losco, A., and Fargion, S. (2001). Increased cancer risk in a cohort of 230 patients with hereditary hemochromatosis in comparison to matched control patients with non-iron-related chronic liver disease. Hepatology 33, p647-651.
34. Fukuda, A., Oda, H., Toyokuni, S., Hiai, H., Satoh, K., and Uchida, K. (1996a). Oxidative stress response in iron-induced renal carcinogenesis: acute nephrotoxicity mediates the enhanced expression of glutathione S-transferase Yp isozyme. Arch Biochem Biophys 329, 39-46.
35. Fukuda, A., Osawa, T., Hitomi, K., and Uchida, K. (1996b). 4-Hydroxy-2-nonenal cytotoxicity in renal proximal tubular cells: protein modification and redox alteration. Arch Biochem Biophys 333, 419-426.
36. Ganz, T. (2003). Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation. Blood 102, 783-788. doi: 10.1182/blood-2003-03-0672.
37. Giorgio, M., Trinei, M., Migliaccio, E., and Pelicci, P.G. (2007). Hydrogen peroxide: a metabolic by-product or a common mediator of ageing signals? Nat Rev Mol Cell Biol 8, 722-728. doi: 10.1038/nrm2240.
38. Halliwell, B., and Gutteridge, J.M.C. (2007). Free radicals in biology and medicine. New York: Oxford University Press.
39. Hanahan, D., and Weinberg, R.A. (2000). The hallmarks of cancer. Cell 100, 57-70.
40. Hao, W., and Friedman, A. (2014). The LDL-HDL profile determines the risk of atherosclerosis: a mathematical model. PLoS One 9, e90497. doi: 10.1371/journal.pone.0090497.
41. Hatayama, I., Nishimura, S., Narita, T., and Sato, K. (1993). Sex-dependent expression of class pi glutathione S-transferase during chemical hepatocarcinogenesis in B6C3F1 mice. Carcinogenesis 14, 537-538.
42. Hentze, M., and Kuhn, L. (1996). Molecular control of vertebrate iron metabolism: mRNA-based regulatory circuits operated by iron, nitric oxide, and oxidative stress. Proc Natl Acad Sci U S A 93, p8175-8182.
43. Hentze, M.W., Muckenthaler, M.U., Galy, B., and Camaschella, C. (2010). Two to tango: regulation of Mammalian iron metabolism. Cell 142, 24-38. doi: 10.1016/j.cell.2010.06.028.
44. Hirayama, T., Okuda, K., and Nagasawa, H. (2013). A highly selective turn-on fluorescent probe fro iron(II) to visualize labile iron in living cells. Chem Sci 4, 1250-1256.
45. Hiroyasu, M., Ozeki, M., Kohda, H., Echizenya, M., Tanaka, T., Hiai, H., and Toyokuni, S. (2002). Specific allelic loss of p16 (INK4A) tumor suppressor gene after weeks of iron-mediated oxidative damage during rat renal carcinogenesis. Am J Pathol 160, 419-424.
46. Holland, J.D., Klaus, A., Garratt, A.N., and Birchmeier, W. (2013). Wnt signaling in stem and cancer stem cells. Curr Opin Cell Biol 25, 254-264. doi: 10.1016/j.ceb.2013.01.004.
47. Hu, Q., Akatsuka, S., Yamashita, Y., Ohara, H., Nagai, H., Okazaki, Y., Takahashi, T., and Toyokuni, S. (2010). Homozygous deletion of CDKN2A/2B is a hallmark of iron-induced high-grade rat mesothelioma. Lab Invest 90, 360-373.
48. Huang, S.X., Wu, F.X., Luo, M., Ma, L., Gao, K.F., Li, J., Wu, W.J., Huang, S., Yang, Q., Liu, K., Zhao, Y.N., and Li, L.Q. (2013). The glutathione S-transferase P1 341C>T polymorphism and cancer risk: a meta-analysis of 28 case-control studies. PLoS One 8, e56722. doi: 10.1371/journal.pone.0056722.
49. Ishii, T., Warabi, E., and Yanagawa, T. (2012). Novel roles of peroxiredoxins in inflammation, cancer and innate immunity. J Clin Biochem Nutr 50, 91-105. doi: 10.3164/jcbn.11-109.
50. Ishimoto, T., Nagano, O., Yae, T., Tamada, M., Motohara, T., Oshima, H., Oshima, M., Ikeda, T., Asaba, R., Yagi, H., Masuko, T., Shimizu, T., Ishikawa, T., Kai, K., Takahashi, E., Imamura, Y., Baba, Y., Ohmura, M., Suematsu, M., Baba, H., and Saya, H. (2011). CD44 variant regulates redox status in cancer cells by stabilizing the xCT subunit of system xc(-) and thereby promotes tumor growth. Cancer Cell 19, 387-400. doi: 10.1016/j.ccr.2011.01.038.
51. Itoh, K., Chiba, T., Takahashi, S., Ishii, T., Igarashi, K., Katoh, Y., Oyake, T., Hayashi, N., Satoh, K., Hatayama, I., Yamamoto, M., and Nabeshima, Y. (1997). An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. Biochem Biophys Res Commun 236, 313-322.
52. Itoh, K., Wakabayashi, N., Katoh, Y., Ishii, T., Igarashi, K., Engel, J.D., and Yamamoto, M. (1999). Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain. Genes Dev 13, 76-86.
53. Jeong, W., Bae, S.H., Toledano, M.B., and Rhee, S.G. (2012). Role of sulfiredoxin as a regulator of peroxiredoxin function and regulation of its expression. Free Radic Biol Med 53, 447-456. doi: 10.1016/j.freeradbiomed.2012.05.020.
54. Jiang, F., Zhang, Y., and Dusting, G.J. (2011). NADPH oxidase-mediated redox signaling: roles in cellular stress response, stress tolerance, and tissue repair. Pharmacol Rev 63, 218-242. doi: 10.1124/pr.110.002980.
55. Jiang, L., Akatsuka, S., Nagai, H., Chew, S.H., Ohara, H., Okazaki, Y., Yamashita, Y., Yoshikawa, Y., Yasui, H., Ikuta, K., Sasaki, K., Kohgo, Y., Hirano, S., Shinohara, Y., Kohyama, N., Takahashi, T., and Toyokuni, S. (2012). Iron overload signature in chrysotile-induced malignant mesothelioma. J Pathol 228, 366-377.
56. Kato, J., Miyanishi, K., Kobune, M., Nakamura, T., Takada, K., Takimoto, R., Kawano, Y., Takahashi, S., Takahashi, M., Sato, Y., Takayama, T., and Niitsu, Y. (2007). Long-term phlebotomy with low-iron diet therapy lowers risk of development of hepatocellular carcinoma from chronic hepatitis C. J Gastroenterol 42, 830-836.
57. Kumar, V., Abbas, A.K., and Aster, J.C. (2013). Robbins Basic Pathology. Philadelphia, PA: Elsevier Saunders.
58. Li, J.L., Okada, S., Hamazaki, S., Ebina, Y., and Midorikawa, O. (1987). Subacute nephrotoxicity and induction of renal cell carcinoma in mice treated with ferric nitrilotriacetate. Cancer Res 47, 1867-1869.
59. Lippard, S.J., and Berg, J.M. (1994). Principles of Bioorganic Chemistry. Mill Valley, CA: University Science Books.
60. Liu, M., and Okada, S. (1994). Induction of free radicals and tumors in the kidneys of Wistar rats by ferric ethylenediamine-N,N'-diacetate. Carcinogenesis 15, 2817-2821.
61. Loeb, L.A. (2001). A mutator phenotype in cancer. Cancer Res 61, 3230-3239.
62. Lu, J., and Holmgren, A. (2014). The thioredoxin antioxidant system. Free Radic Biol Med 66, 75-87. doi: 10.1016/j.freeradbiomed.2013.07.036.
63. Miller, D.M., Buettner, G.R., and Aust, S.D. (1990). Transition metals as catalysts of "autoxidation" reactions. Free Radic Biol Med 8, 95-108.
64. Minotti, G., and Aust, S.D. (1989). The role of iron in oxygen radical mediated lipid peroxidation. Chem Biol Interact 71, 1-19.
65. Mitsuishi, Y., Motohashi, H., and Yamamoto, M. (2012). The Keap1-Nrf2 system in cancers: stress response and anabolic metabolism. Front Oncol 2, 200. doi: 10.3389/fonc.2012.00200.
66. Mukaide, T., Hattori, Y., Misawa, N., Funahashi, S., Jiang, L., Hirayama, T., Nagasawa, H., and Toyokuni, S. (2014). Histological detection of catalytic ferrous iron with the selective turn-on fluorescent probe RhoNox-1 in a Fenton reaction-based rat renal carcinogenesis model. Free Radic Res. doi: 10.3109/10715762.2014.898844.
67. Munday, R. (1989). Toxicity of thiols and disulphides: involvement of free-radical species. Free Radic Biol Med 7, 659-673.
68. Nagai, H., Okazaki, Y., Chew, S., Misawa, N., Yamashita, Y., Akatsuka, S., Yamashita, K., Ishihara, T., Yoshikawa, Y., Jiang, L., Ohara, H., Takahashi, T., Ichihara, G., Kostarelos, K., Miyata, Y., Shinohara, H., and Toyokuni, S. (2011). Diameter of multi-walled carbon nanotubes is a critical factor in mesothelial injury and subsequent carcinogenesis. Proc Natl Acad Sci U S A 108, E1330-1338.
69. Nishida, M., Sawa, T., Kitajima, N., Ono, K., Inoue, H., Ihara, H., Motohashi, H., Yamamoto, M., Suematsu, M., Kurose, H., Van Der Vliet, A., Freeman, B.A., Shibata, T., Uchida, K., Kumagai, Y., and Akaike, T. (2012). Hydrogen sulfide anion regulates redox signaling via electrophile sulfhydration. Nat Chem Biol 8, 714-724. doi: 10.1038/nchembio.1018.
70. Nishiyama, Y., Suwa, H., Okamoto, K., Fukumoto, M., Hiai, H., and Toyokuni, S. (1995). Low incidence of point mutations in H-, K- and N-ras oncogenes and p53 tumor suppressor gene in renal cell carcinoma and peritoneal mesothelioma of Wistar rats induced by ferric nitrilotriacetate. Jpn J Cancer Res 86, 1150-1158.
71. Nogueira, V., and Hay, N. (2013). Molecular pathways: reactive oxygen species homeostasis in cancer cells and implications for cancer therapy. Clin Cancer Res 19, 4309-4314. doi: 10.1158/1078-0432.CCR-12-1424.
72. Noto, J.M., Gaddy, J.A., Lee, J.Y., Piazuelo, M.B., Friedman, D.B., Colvin, D.C., Romero-Gallo, J., Suarez, G., Loh, J., Slaughter, J.C., Tan, S., Morgan, D.R., Wilson, K.T., Bravo, L.E., Correa, P., Cover, T.L., Amieva, M.R., and Peek, R.M., Jr. (2013). Iron deficiency accelerates Helicobacter pylori-induced carcinogenesis in rodents and humans. J Clin Invest 123, 479-492. doi: 10.1172/JCI64373.
73. Ohnishi, K., Semi, K., Yamamoto, T., Shimizu, M., Tanaka, A., Mitsunaga, K., Okita, K., Osafune, K., Arioka, Y., Maeda, T., Soejima, H., Moriwaki, H., Yamanaka, S., Woltjen, K., and Yamada, Y. (2014). Premature termination of reprogramming in vivo leads to cancer development through altered epigenetic regulation. Cell 156, 663-677. doi: 10.1016/j.cell.2014.01.005.
74. Okada, S. (1996). Iron-induced tissue damage and cancer: The role of reactive oxygen free radicals. Pathol Int 46, 311-332.
75. Okada, S., Hamazaki, S., Toyokuni, S., and Midorikawa, O. (1989). Induction of mesothelioma by intraperitoneal injections of ferric saccharate in male Wistar rats. Br J Cancer 60, 708-711.
76. Okada, S., and Midorikawa, O. (1982). Induction of rat renal adenocarcinoma by Fe-nitrilotriacetate (Fe-NTA). Jpn Arch Intern Med 29, 485-491.
77. Okada, S., Minamiyama, Y., Hamazaki, S., Toyokuni, S., and Sotomatsu, A. (1993). Glutathione cycle dependency of ferric nitrilotriacetate-induced lipid peroxidation in mouse proximal renal tubules. Arch Biochem Biophys 301, 138-142.
78. Pearce, C.L., Templeman, C., Rossing, M.A., Lee, A., Near, A.M., Webb, P.M., Nagle, C.M., Doherty, J.A., Cushing-Haugen, K.L., Wicklund, K.G., Chang-Claude, J., Hein, R., Lurie, G., Wilkens, L.R., Carney, M.E., Goodman, M.T., Moysich, K., Kjaer, S.K., Hogdall, E., Jensen, A., Goode, E.L., Fridley, B.L., Larson, M.C., Schildkraut, J.M., Palmieri, R.T., Cramer, D.W., Terry, K.L., Vitonis, A.F., Titus, L.J., Ziogas, A., Brewster, W., Anton-Culver, H., Gentry-Maharaj, A., Ramus, S.J., Anderson, A.R., Brueggmann, D., Fasching, P.A., Gayther, S.A., Huntsman, D.G., Menon, U., Ness, R.B., Pike, M.C., Risch, H., Wu, A.H., Berchuck, A., and Ovarian Cancer Association, C. (2012). Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studies. Lancet Oncol 13, 385-394. doi: 10.1016/S1470-2045(11)70404-1.
79. Penney, R.B., and Roy, D. (2013). Thioredoxin-mediated redox regulation of resistance to endocrine therapy in breast cancer. Biochim Biophys Acta 1836, 60-79. doi: 10.1016/j.bbcan.2013.02.005.
80. Pleasance, E.D., Cheetham, R.K., Stephens, P.J., Mcbride, D.J., Humphray, S.J., Greenman, C.D., Varela, I., Lin, M.L., Ordonez, G.R., Bignell, G.R., Ye, K., Alipaz, J., Bauer, M.J., Beare, D., Butler, A., Carter, R.J., Chen, L., Cox, A.J., Edkins, S., Kokko-Gonzales, P.I., Gormley, N.A., Grocock, R.J., Haudenschild, C.D., Hims, M.M., James, T., Jia, M., Kingsbury, Z., Leroy, C., Marshall, J., Menzies, A., Mudie, L.J., Ning, Z., Royce, T., Schulz-Trieglaff, O.B., Spiridou, A., Stebbings, L.A., Szajkowski, L., Teague, J., Williamson, D., Chin, L., Ross, M.T., Campbell, P.J., Bentley, D.R., Futreal, P.A., and Stratton, M.R. (2010). A comprehensive catalogue of somatic mutations from a human cancer genome. Nature 463, 191-196. doi: 10.1038/nature08658.
81. Pootrakul, P., Christensen, A., Josephson, B., and Finch, C.A. (1977). Role of transferrin in determining internal iron distribution. Blood 49, 957-966.
82. Quig, D. (1998). Cysteine metabolism and metal toxicity. Altern Med Rev 3, 262-270.
83. Rhee, S.G., Chae, H.Z., and Kim, K. (2005). Peroxiredoxins: a historical overview and speculative preview of novel mechanisms and emerging concepts in cell signaling. Free Radic Biol Med 38, 1543-1552. doi: 10.1016/j.freeradbiomed.2005.02.026.
84. Richmond, H.G. (1959). Induction of sarcoma in the rat by iron-dextran complex. Br Med J i, 947-949.
85. Samuni, A., Aronovich, J., Godinger, D., Chevion, M., and Czapski, G. (1983). On the toxicity of vitamin C and metal ions: a site-specific Fenton mechanism. Eur J Biochem 137, 119-124.
86. Schenk, H., Klein, M., Erdbruegger, W., Droege, W., and Schulze-Osthoff, K. (1994). Distinct effects of thioredoxin and antioxidants on the activation of transcription factors NF-kB and AP-1. Proc Natl Acad Sci U S A 91, 1672-1676.
87. Schmucker, S., Martelli, A., Colin, F., Page, A., Wattenhofer-Donze, M., Reutenauer, L., and Puccio, H. (2011). Mammalian frataxin: an essential function for cellular viability through an interaction with a preformed ISCU/NFS1/ISD11 iron-sulfur assembly complex. PLoS One 6, e16199. doi: 10.1371/journal.pone.0016199.
88. Scott, A.M., Wolchok, J.D., and Old, L.J. (2012). Antibody therapy of cancer. Nat Rev Cancer 12, 278-287. doi: 10.1038/nrc3236.
89. Shaw, G.C., Cope, J.J., Li, L., Corson, K., Hersey, C., Ackermann, G.E., Gwynn, B., Lambert, A.J., Wingert, R.A., Traver, D., Trede, N.S., Barut, B.A., Zhou, Y., Minet, E., Donovan, A., Brownlie, A., Balzan, R., Weiss, M.J., Peters, L.L., Kaplan, J., Zon, L.I., and Paw, B.H. (2006). Mitoferrin is essential for erythroid iron assimilation. Nature 440, 96-100. doi: 10.1038/nature04512.
90. Sies, H. (1999). Glutathione and its role in cellular functions. Free Radic Biol Med 27, 916-921.
91. Sies, H. (2014). Role of metabolic H2O2 generation: redox signaling and oxidative stress. J Biol Chem 289, 8735-8741. doi: 10.1074/jbc.R113.544635.
92. Smith, A.E., Mohamedali, A.M., Kulasekararaj, A., Lim, Z., Gaken, J., Lea, N.C., Przychodzen, B., Mian, S.A., Nasser, E.E., Shooter, C., Westwood, N.B., Strupp, C., Gattermann, N., Maciejewski, J.P., Germing, U., and Mufti, G.J. (2010). Next-generation sequencing of the TET2 gene in 355 MDS and CMML patients reveals low-abundance mutant clones with early origins, but indicates no definite prognostic value. Blood 116, 3923-3932. doi: 10.1182/blood-2010-03-274704.
93. Stratton, M.R., Campbell, P.J., and Futreal, P.A. (2009). The cancer genome. Nature 458, 719-724. doi: 10.1038/nature07943.
94. Suzuki, T., Motohashi, H., and Yamamoto, M. (2013). Toward clinical application of the Keap1-Nrf2 pathway. Trends Pharmacol Sci 34, 340-346. doi: 10.1016/j.tips.2013.04.005.
95. Tanaka, T., Akatsuka, S., Ozeki, M., Shirase, T., Hiai, H., and Toyokuni, S. (2004). Redox regulation of annexin 2 and its implications for oxidative stess-induced renal carcinogenesis and metastasis. Oncogene 23, 3980-3989.
96. Tanaka, T., Iwasa, Y., Kondo, S., Hiai, H., and Toyokuni, S. (1999). High incidence of allelic loss on chromosome 5 and inactivation of p15 INK4B and p16 INK4A tumor suppressor genes in oxystress-induced renal cell carcinoma of rats. Oncogene 18, 3793-3797.
97. Tanaka, T., Kondo, S., Iwasa, Y., Hiai, H., and Toyokuni, S. (2000). Expression of stress-response and cell proliferation genes in renal cell carcinoma induced by oxidative stress. Am J Pathol 156, p2149-2157.
98. Tanaka, T., Nishiyama, Y., Okada, K., Hirota, K., Matsui, M., Yodoi, J., Hiai, H., and Toyokuni, S. (1997). Induction and nuclear translocation of thioredoxin by oxidative damage in the mouse kidney: independence of tubular necrosis and sulfhydryl depletion. Lab Invest 77, 145-155.
99. Tanaka, T., Nishiyama, Y., Okada, K., Satoh, K., Fukuda, A., Uchida, K., Osawa, T., Hiai, H., and Toyokuni, S. (1998). Over-expression of glutathione S-transferase Yp isozyme and concomitant down-regulation of Ya isozyme in renal cell carcinoma of rats induced by ferric nitrilotriacetate. Carcinogenesis 19, 897-903.
100. Tang, S.C., Wu, C.H., Lai, C.H., Sung, W.W., Yang, W.J., Tang, L.C., Hsu, C.P., and Ko, J.L. (2013). Glutathione S-transferase mu2 suppresses cancer cell metastasis in non-small cell lung cancer. Mol Cancer Res 11, 518-529. doi: 10.1158/1541-7786.MCR-12-0488.
101. Toyokuni, S. (1996). Iron-induced carcinogenesis: the role of redox regulation. Free Radic Biol Med 20, 553-566.
102. Toyokuni, S. (2002). Iron and carcinogenesis: from Fenton reaction to target genes. Redox Rep 7, 189-197.
103. Toyokuni, S. (2009). Role of iron in carcinogenesis: Cancer as a ferrotoxic disease. Cancer Sci 100, 9-16.
104. Toyokuni, S. (2011a). Iron as a target of chemoprevention for longevity in humans. Free Radic Res 45, 906-917.
105. Toyokuni, S. (2011b). Mysterious link between iron overload and CDKN2A/2B. J Clin Biochem Nutr 48, 46-49.
106. Toyokuni, S. (2013a). Genotoxicity and carcinogenicity risk of carbon nanotubes [epub ahead of print] [Record Supplied By Publisher]. Adv Drug Deliv Rev 65, 2098-2110.
107. Toyokuni, S. (2013b). Iron overload as a major targetable pathogenesis of asbestos-induced mesothelial carcinogenesis. Redox Rep 19, 1-7. doi: 10.1179/1351000213Y.0000000075.
108. Toyokuni, S., Luo, X.P., Tanaka, T., Uchida, K., Hiai, H., and Lehotay, D.C. (1997a). Induction of a wide range of C2-12 aldehydes and C7-12 acyloins in the kidney of Wistar rats after treatment with a renal carcinogen, ferric nitrilotriacetate. Free Radic Biol Med 22, 1019-1027.
109. Toyokuni, S., Mori, T., and Dizdaroglu, M. (1994a). DNA base modifications in renal chromatin of Wistar rats treated with a renal carcinogen, ferric nitrilotriacetate. Int J Cancer 57, 123-128.
110. Toyokuni, S., Mori, T., Hiai, H., and Dizdaroglu, M. (1995a). Treatment of Wistar rats with a renal carcinogen, ferric nitrilotriacetate, causes DNA-protein cross-linking between thymine and tyrosine in their renal chromatin. Int J Cancer 62, 309-313.
111. Toyokuni, S., Okada, S., Hamazaki, S., Minamiyama, Y., Yamada, Y., Liang, P., Fukunaga, Y., and Midorikawa, O. (1990). Combined histochemical and biochemical analysis of sex hormone dependence of ferric nitrilotriacetate-induced renal lipid peroxidation in ddY mice. Cancer Res 50, 5574-5580.
112. Toyokuni, S., Okamoto, K., Yodoi, J., and Hiai, H. (1995b). Persistent oxidative stress in cancer. FEBS Lett 358, 1-3.
113. Toyokuni, S., and Sagripanti, J.-L. (1993). DNA single- and double-strand breaks produced by ferric nitrilotriacetate in relation to renal tubular carcinogenesis. Carcinogenesis 14, 223-227.
114. Toyokuni, S., and Sagripanti, J.-L. (1996). Association between 8-hydroxy-2'-deoxyguanosine formation and DNA strand breaks mediated by copper and iron. Free Radic Biol Med 20, 859-864.
115. Toyokuni, S., and Sagripanti, J.L. (1992). Iron-mediated DNA damage: sensitive detection of DNA strand breakage catalyzed by iron. J Inorg Biochem 47, 241-248.
116. Toyokuni, S., Tanaka, T., Hattori, Y., Nishiyama, Y., Ochi, H., Hiai, H., Uchida, K., and Osawa, T. (1997b). Quantitative immunohistochemical determination of 8-hydroxy-2'-deoxyguanosine by a monoclonal antibody N45.1: its application to ferric nitrilotriacetate-induced renal carcinogenesis model. Lab Invest 76, 365-374.
117. Toyokuni, S., Uchida, K., Okamoto, K., Hattori-Nakakuki, Y., Hiai, H., and Stadtman, E.R. (1994b). Formation of 4-hydroxy-2-nonenal-modified proteins in the renal proximal tubules of rats treated with a renal carcinogen, ferric nitrilotriacetate. Proc Natl Acad Sci U S A 91, 2616-2620.
118. Traverso, N., Ricciarelli, R., Nitti, M., Marengo, B., Furfaro, A.L., Pronzato, M.A., Marinari, U.M., and Domenicotti, C. (2013). Role of glutathione in cancer progression and chemoresistance. Oxid Med Cell Longev 2013, 972913. doi: 10.1155/2013/972913.
119. Travis, L.B., Demark Wahnefried, W., Allan, J.M., Wood, M.E., and Ng, A.K. (2013). Aetiology, genetics and prevention of secondary neoplasms in adult cancer survivors. Nat Rev Clin Oncol 10, 289-301. doi: 10.1038/nrclinonc.2013.41.
120. Uchida, K., Fukuda, A., Kawakishi, S., Hiai, H., and Toyokuni, S. (1995). A renal carcinogen ferric nitrilotriacetate mediates a temporary accumulation of aldehyde-modified proteins within cytosolic compartment of rat kidney. Arch Biochem Biophys 317, 405-411.
121. Wang, R.H., Li, C., Xu, X., Zheng, Y., Xiao, C., Zerfas, P., Cooperman, S., Eckhaus, M., Rouault, T., Mishra, L., and Deng, C.X. (2005). A role of SMAD4 in iron metabolism through the positive regulation of hepcidin expression. Cell Metab 2, 399-409. doi: 10.1016/j.cmet.2005.10.010.
122. Weinberg, R.A. (2013). The biology of cancer, second ed. New York: Garland Science, Tailor & Francis Group, LLC.
123. Welsh, J.L., Wagner, B.A., Van't Erve, T.J., Zehr, P.S., Berg, D.J., Halfdanarson, T.R., Yee, N.S., Bodeker, K.L., Du, J., Roberts, L.J., 2nd, Drisko, J., Levine, M., Buettner, G.R., and Cullen, J.J. (2013). Pharmacological ascorbate with gemcitabine for the control of metastatic and node-positive pancreatic cancer (PACMAN): results from a phase I clinical trial. Cancer Chemother Pharmacol 71, 765-775. doi: 10.1007/s00280-013-2070-8.
124. Winterbourn, C.C. (2013). The biological chemistry of hydrogen peroxide. Methods Enzymol 528, 3-25. doi: 10.1016/B978-0-12-405881-1.00001-X.
125. Wood, Z.A., Poole, L.B., and Karplus, P.A. (2003). Peroxiredoxin evolution and the regulation of hydrogen peroxide signaling. Science 300, 650-653. doi: 10.1126/science.1080405.
126. Wriggleworth, J.M., and Baum, H. (1980). "The biochemical function of iron," in Iron in biochemistry and medicine, II, eds. A. Jacobs & M. Worwood. (London: Academic Press), 29-86.
127. Yamaguchi, K., Mandai, M., Toyokuni, S., Hamanishi, J., Higuchi, T., Takakura, K., and Fujii, S. (2008). Contents of endometriotic cysts, especially the high concentration of free iron, are a possible cause of carcinogenesis in the cysts through the iron-induced persistent oxidative stress. Clin Cancer Res 14, p32-40.
128. Yamashita, Y., Akatsuka, S., Shinjo, K., Yatabe, Y., Kobayashi, H., Seko, H., Kajiyama, H., Kikkawa, F., Takahashi, T., and Toyokuni, S. (2013). Met is the most frequently amplified gene in endometriosis-associated ovarian clear cell adenocarcinoma and correlates with worsened prognosis. PLoS One 8, e57724.
129. Yang, G., Wu, L., Jiang, B., Yang, W., Qi, J., Cao, K., Meng, Q., Mustafa, A.K., Mu, W., Zhang, S., Snyder, S.H., and Wang, R. (2008). H2S as a physiologic vasorelaxant: hypertension in mice with deletion of cystathionine gamma-lyase. Science 322, 587-590. doi: 10.1126/science.1162667.
130. Zacharski, L., Chow, B., Howes, P., Shamayeva, G., Baron, J., Dalman, R., Malenka, D., Ozaki, C., and Lavori, P. (2007). Reduction of iron stores and cardiovascular outcomes in patients with peripheral arterial disease: a randomized controlled trial. JAMA 297, 603-610.
131. Zhang, Y. (2005). The magic bullets and tuberculosis drug targets. Annu Rev Pharmacol Toxicol 45, 529-564.
132. Zhou, S., Lien, Y.C., Shuvaeva, T., Debolt, K., Feinstein, S.I., and Fisher, A.B. (2013). Functional interaction of glutathione S-transferase pi and peroxiredoxin 6 in intact cells. Int J Biochem Cell Biol 45, 401-407. doi: 10.1016/j.biocel.2012.11.005.